인쇄하기
취소

LG, AstraZeneca to co-market Vimovo in Korea

Published: 2012-07-26 06:56:00
Updated: 2012-07-26 06:56:00
LG Life Sciences (LGLC) and AstraZeneca Korea (AZK) Tuesday announced that the two companies have signed an agreement to co-market AZK’s Vimovo tablets from next month in Korea.

Vimovo contains a combination of esomeprazole and naproxen. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). It works by reducing substances in the body that cause inflammation, pain, and fever. Esomeprazol...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.